Iovance Biotherapeutics, Inc. ( IOVA) - Key Metrics
IOVA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.21 | -$0.18 | -$0.13 | -$0.15 |
| 2025Q3 | $0.19 | -$0.25 | -$0.22 | -$0.25 |
| 2025Q2 | $0.18 | -$0.33 | -$0.20 | -$0.22 |
| 2025Q1 | $0.15 | -$0.36 | -$0.32 | -$0.34 |
IOVA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.86 |
| 2025Q3 | ? | -2.16 |
| 2025Q2 | ? | -1.29 |
| 2025Q1 | ? | -2.31 |
IOVA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -5.36% | ? |
| 2025Q4 | -5.57% | ? |
| 2025Q3 | -11.34% | ? |
| 2025Q2 | -13.02% | ? |
| 2025Q1 | -10.22% | ? |
IOVA
Price: $4.03
52 week price:
Earnings Per Share: -0.92 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.5 million
Ebitda: -22.1 millionMarket Capitalization: 1.5 billion